News

Apply for a share of up to £25 million for ambitious or disruptive R&D innovations

Published on: 02/07/2019

Apply for a share of up to £25 million for ambitious or disruptive R&D innovations
Funding
Member News, Funding news

Secure the funding you need to progress your projects towards commercialisation.

We’re looking for game changing, disruptive, and innovative companies to partner with for the Innovate UK Smart Grants: April 2019.

Summary

Opportunity to apply for a share of up to £25 million to deliver ambitious or disruptive R&D innovations with significant potential for impact on the UK economy.

Closes: Wednesday 24th July 2019
OrganisationInnovate UK
GuidelinesRead the full competition details >

Why partner with the Medicines Discovery Catapult?

  • Our experienced commercial and scientific teams have connections across industry, academia, finance, government, and research networks – we can help take your projects further towards commercial viability.
  • We have specialist grant writing expertise to work with you in crafting top quality grant applications.
  • Our team have a wealth of industrial and academic expertise applied to drug discovery, complex cell models, assay development, biomarker identification, and validation.
  • You’ll have supported access, with specialist expertise, to cutting edge technologies including multi-omics capabilities, mass spec quantitationmass spec imaging, and organ-on-a-chip capabilities.
  • Our team are experts in translating analytical methodologies that are sensitive, specific, and robust for clinical utility.
  • Our Informatics team have deep expertise in natural language processing, data analysis, machine learning, cheminformatics, and bioinformatics.
  • We can providing access to information thats not readily available around target validation, drug target interaction, and downstream consequences of engagement.
  • We can help unlock access to appropriately consented patient Samples & Data.
  • We’ll give you access to a network of clinical, academic, and industry experts via Virtual R&D.

NEWS​

Related News

VUGENE secures 1 million Euros to revolutionize biological research

7 May 2025
VUGENE, a Lithuania-based multi-omics data analysis company, has announced the closing an investment round of €1 million, led by Superhero Capital tog...

AMR EDUCare: Empowering europe’s healthcare professionals to tackle antimicrobial resistance

6 May 2025

Connect, Innovate, and Transform Healthcare at the AHB Symposium 2025

6 May 2025

Shaping the Future of Digital Health: Insights from the Foresight 2030 Study

6 May 2025

MedFIT 2025

6 May 2025

Have your say: Open Public Consultation for the BeWell Skills Strategy (DUPLICATE)

6 May 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *